Daiwa Securities Group
HARP

Daiwa Securities Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Daiwa Securities Group’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed – – 1418
2022
Q3 		$0 Hold
5
– – ﹤0.01% 1425
2022
Q2 		$0 Hold
5
– – ﹤0.01% 1459
2022
Q1 		$0 Hold
5
– – ﹤0.01% 1438
2021
Q4 		$0 Hold
5
– – ﹤0.01% 1472
2021
Q3 		$0 Hold
5
– – ﹤0.01% 1355
2021
Q2 		$1K Hold
5
– – ﹤0.01% 1239
2021
Q1 		$1K Hold
5
– – ﹤0.01% 1250
2020
Q4 		$1K Buy
+5
New +$773 ﹤0.01% 1232

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Daiwa Securities Group's HARP Position: Q4 2022 in Review

Daiwa Securities Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2022, closing a stake of 5 shares.

Daiwa Securities Group first reported a position in HARP in Q4 2020 and held it in 8 quarters. The position peaked at $1K in Q2 2021. 49 funds tracked by Wall St. Rank hold HARP as of Q4 2022.

  • Daiwa Securities Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 5 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Daiwa Securities Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.